drugset / Trial / NCT01435915

Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

NCT01435915

Phase 1 Completed 24 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the pharmacokinetic profile of ropinirole PR after single and multiple doses of the PR-formulation. It will also investigate the safety and tolerability of ropinirole PR after single and multiple doses of PR-formulation.

Timeline

Start
2010-06-28
Primary completion
2010-08-05
Completion
2010-08-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule 2 mg Oral

Indications